REGN vs GOOGL: Which Stock is Better?

Side-by-side comparison of Regeneron Pharmaceuticals Inc and Alphabet Inc in 2026

Comparison Updated:

REGN

Regeneron Pharmaceuticals Inc

$781.67

GOOGL

Alphabet Inc

$315.20

Key Metrics Comparison

MetricREGNGOOGLWinner
Market Cap$82.64BN/AREGN
P/E Ratio18.8328.58REGN
EPS (TTM)$41.51$10.95REGN
Revenue Growth0.0%15.1%GOOGL
Gross Margin44.6%59.7%GOOGL

Analyze REGN

Full quant analysis

Analyze GOOGL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is REGN or GOOGL a better investment?

Comparing REGN and GOOGL: Regeneron Pharmaceuticals Inc has a market cap of $82.64B while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between REGN and GOOGL?

REGN (Regeneron Pharmaceuticals Inc) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: REGN or GOOGL?

Based on P/E ratios, REGN trades at a lower multiple (18.8x vs 28.6x).

Which is growing faster: REGN or GOOGL?

GOOGL has higher revenue growth at 15.1% vs 0.0% for REGN.

Which company is more profitable: REGN or GOOGL?

Alphabet Inc (GOOGL) has higher gross margins at 59.7% compared to 44.6% for REGN.

Which is the larger company: REGN or GOOGL?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $82.64B compared to N/A for GOOGL.

Should I buy REGN or GOOGL in 2026?

Both REGN and GOOGL have investment merit. REGN trades at $781.67 while GOOGL trades at $315.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between REGN and GOOGL stock?

Key differences: Market Cap ($82.64B vs N/A), P/E Ratio (18.8x vs 28.6x), Revenue Growth (0.0% vs 15.1%), Gross Margin (44.6% vs 59.7%).

Popular Stock Comparisons